31 March 2026 - Cell-free DNA testing company Natera Inc (NASDAQ:NTRA) on Tuesday reported publication of a prospective study in Clinical Cancer Research demonstrating that its Signatera molecular residual disease (MRD) test can help identify older p...
31 March 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) on Tuesday reported positive results from its global Phase III clinical programme evaluating efzimfotase alfa for hypophosphatasia, a rare metabolic disease.The ...
31 March 2026 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) announced on Tuesday that the European Commission has granted marketing authorisation for EURneffy 1 mg, enabling a needle-free adrenaline treatment for anaphylaxis...
31 March 2026 - Belgian biotechnology company Galapagos NV (Euronext Brussels:GLPG) (NASDAQ:GLPG) announced on Tuesday that it has entered into a binding agreement with US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) to collaborate on ...